Manipal Health Enterprises (NSE:MANIPALHOS) EV-to-EBITDA: (As of Aug. 30, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:MANIPALHOS Manipal Health Enterprises Ltd NSE:MANIPALHOS
13 GF Score
Price ₹771.65
! 1 Warning Sign
View Full Analysis

What is Manipal Health Enterprises EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Manipal Health Enterprises's enterprise value is ₹1,119,259 Mil. Manipal Health Enterprises does not have enough years/quarters to calculate its EBITDA for the trailing twelve months (TTM) ended in Mar. 2026. Therefore, GuruFocus does not calculate Manipal Health Enterprises's EV-to-EBITDA at this moment.

The historical rank and industry rank for Manipal Health Enterprises's EV-to-EBITDA or its related term are showing as below:

NSE:MANIPALHOS' s EV-to-EBITDA Range Over the Past 10 Years
Min: 35.13   Med: 36.68   Max: 39.48
Current: 39.48

During the past 3 years, the highest EV-to-EBITDA of Manipal Health Enterprises was 39.48. The lowest was 35.13. And the median was 36.68.

NSE:MANIPALHOS's EV-to-EBITDA is ranked worse than
90.1% of 515 companies
in the Healthcare Providers & Services industry
Industry Median: 10.62 vs NSE:MANIPALHOS: 39.48

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2026-08-30), Manipal Health Enterprises's stock price is ₹771.65. Manipal Health Enterprises does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026. Therefore, GuruFocus does not calculate Manipal Health Enterprises's PE Ratio (TTM) at this moment.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).

Manipal Health Enterprises  (NSE:MANIPALHOS) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Manipal Health Enterprises's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=771.65/
=

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?

Manipal Health Enterprises EV-to-EBITDA Related Terms

Manipal Health Enterprises EV-to-EBITDA Historical Data

* Premium members only.

The historical data trend for Manipal Health Enterprises's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Manipal Health Enterprises EV-to-EBITDA Chart

Manipal Health Enterprises Annual Data
Trend Mar24 Mar25 Mar26
EV-to-EBITDA
0.00 0.00 0.00

Manipal Health Enterprises Semi-Annual Data
Mar24 Mar25 Mar26
EV-to-EBITDA 0.00 0.00 0.00

NSE:MANIPALHOS vs : EV-to-EBITDA Comparison

For the Medical Care Facilities subindustry, Manipal Health Enterprises's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Manipal Health Enterprises EV-to-EBITDA vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Manipal Health Enterprises's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Manipal Health Enterprises's EV-to-EBITDA falls into.


NSE:MANIPALHOS
13GF Score
Manipal Health Enterprises Ltd NSE:MANIPALHOS
EV-to-EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Manipal Health Enterprises EV-to-EBITDA Calculation

Manipal Health Enterprises's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=1119258.998/
=

Manipal Health Enterprises Business Description

Comparable Companies
Other Exchanges 544847:India
Address HAL Airport Road, Rustom Bagh road, The Annexe, no. 98/2, Bengaluru, KA, IND, 560 017
Manipal Health Enterprises Ltd is engaged in the business of running/managing hospitals and providing healthcare services. The company operates through various Hospitals/clinics providing Healthcare services and diagnostic centres in India. It offers clinical services across several specialties, with a focus on tertiary and quaternary care, particularly in cardiac sciences, oncology, neurosciences, gastro sciences, orthopedics, and renal sciences. It has a single business segment, namely engaged in the business of healthcare services. The company generates revenue by providing inpatient care at its hospitals.
13GF Score

Get the complete analysis for NSE:MANIPALHOS

EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹771.65
Price